
SMLR Earnings
Semler Scientific Inc
Earning Analysis
Welcome to our in-depth analysis of Semler Scientific Inc(SMLR) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Semler Scientific Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q2 | 2025-08-04 | After Hours | -0.27 | 5.04 | +1966.67 | 8.40M | 8.22M | -2.19 | -1.41 | +2.15 |
| - | 2025-05-13 | After Hours | - | -6.74 | - | - | 8.84M | - | -11.34 | +17.90 |
| - | 2025-02-18 | After Hours | 0.20 | 3.41 | +1605.00 | 12.00M | 12.41M | +3.44 | +2.96 | -16.36 |
| FY2024Q3 | 2024-11-04 | After Hours | 0.37 | 0.72 | +94.59 | 13.10M | 13.51M | +3.15 | +30.13 | +73.97 |
| FY2024Q2 | 2024-08-05 | - | - | 0.00 | - | 18.60M | 14.47M | -22.23 | -9.55 | -2.03 |
| FY2024Q1 | 2024-05-07 | - | - | 0.78 | - | 21.40M | 15.90M | -25.69 | +1.73 | -16.57 |
| FY2023Q4 | 2024-03-05 | - | - | 0.55 | - | 14.50M | 15.06M | +3.83 | -19.04 | -37.48 |
| - | 2022-11-01 | - | 0.37 | 0.46 | +24.32 | - | - | - | +2.36 | -31.44 |
| - | 2022-08-02 | - | 0.40 | 0.51 | +27.50 | - | - | - | +0.45 | +28.50 |
| - | 2022-05-02 | - | 0.51 | 0.41 | -19.61 | - | - | - | +2.94 | -31.12 |
SMLR Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Semler Scientific Inc reported performance for FY2025Q2, announced on 2025-08-04. The company achieved an EPS of 5.04, compared to analyst estimates of -0.27 by 1966.67% . Revenue for the quarter reached 8.22M compared to expectations of 8.40M by -2.19% .
The stock price reacted with a -1.41% one-day change and a 2.15% five-day change following the earnings release. These movements reflect market reaction in Semler Scientific Inc growth trajectory and strategic initiatives.
SMLR Earnings Forecast
Looking ahead, Semler Scientific Inc(SMLR) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 7.87M and an EPS of -0.15.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -5.19%, while EPS estimates have been Revise Upward by 31.65%. For the upcoming Q3 2025, revenue estimates have been adjusted Revise Downward by -2.08% . These revisions correlate with a -25.19% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Semler Scientific Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between SMLR's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward

-5.19%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+31.65%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Downward

-2.08%
In Past 3 Month
Stock Price
Go Down

-25.19%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:31.56M
--
EPS Estimate-Annual FY 2025:-3.66
—
Stock Price26.46
SMLR Revenue and EPS Performance: A Historical Perspective
Semler Scientific Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-04,After Hours):
EPS: 5.04 (Actual) vs.-0.27 (Estimate) (1966.67%)
Revenue: 8.22M (Actual) vs. 8.40M (Estimate) (-2.19%)
Price Reaction: -1.41%(1-Day), 2.15%(5-Day)
(2025-05-13,After Hours):
EPS: -6.74 (Actual) vs. (Estimate) (%)
Revenue: 8.84M (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -11.34%(1-Day), 17.90%(5-Day)
(2025-02-18,After Hours):
EPS: 3.41 (Actual) vs.0.20 (Estimate) (1605.00%)
Revenue: 12.41M (Actual) vs. 12.00M (Estimate) (3.44%)
Price Reaction: 2.96%(1-Day), -16.36%(5-Day)
Earnings Reaction
The chart below shows how SMLR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, SMLR sees a +1.51% change in stock price 10 days leading up to the earnings, and a -1.60% change 10 days following the report. On the earnings day itself, the stock moves by -1.33%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -1.41% on the day following the earnings release and then changed by -4.55% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Semler Scientific Inc (SMLR) Q2 2025 Earnings Call Summary
Negative
2025-08-04
The earnings call reveals several concerns: declining revenue and operating losses in the healthcare segment, significant risk from heavy Bitcoin investments, legal expenses from a DOJ settlement, and reliance on equity issuance, which could dilute shareholder value. While there is a positive Bitcoin yield, the volatility and risks associated with Bitcoin, combined with a weak healthcare business performance, outweigh the positives. The Q&A session did not alleviate these concerns, as management's optimism about Bitcoin adoption does not mitigate the financial and operational risks. Overall, these factors suggest a negative stock price reaction.
Semler Scientific Inc (SMLR) Q1 2025 Earnings Call Summary
Negative
2025-05-14
The earnings call highlights a strong focus on Bitcoin acquisitions, which exposes the company to volatility and regulatory risks. Despite cash generation and Bitcoin gains, the healthcare business faces challenges and lacks clear growth guidance. The $500 million ATM program and convertible notes increase financial leverage. The Q&A session reveals concerns about unclear management responses and potential declines in healthcare revenue. These factors, along with the economic and competitive pressures, suggest a negative sentiment, likely resulting in a stock price decline of -2% to -8%.
Semler Scientific Inc (SMLR) Q1 2025 Earnings Call Summary
Negative
2025-05-13
The earnings call highlights significant financial struggles, including a 44% revenue decline, operational losses, and liquidity concerns. Despite ambitious Bitcoin acquisition plans, the volatility poses financial risks. Regulatory issues add uncertainty, and the management's vague future outlook further exacerbates investor concerns. The overall sentiment is strongly negative, with potential stock decline exceeding -8%.
Semler Scientific Inc (SMLR) Q4 2024 Earnings Call Summary
Neutral
2025-02-19
The company's earnings call presents mixed signals. While there are strong positives like record cash generation, significant Bitcoin holdings, and EPS exceeding expectations, there are also concerns. The absence of a shareholder return plan, potential regulatory risks, and market risks associated with Bitcoin introduce uncertainties. Moreover, management's lack of clarity on 2025 expectations and the reliance on Bitcoin performance pose potential downsides. The convertible note offering and market capitalization growth are positive, but the overall sentiment remains neutral due to the balance of risks and opportunities.
Semler Scientific, Inc. (SMLR) Q3 2024 Earnings Call Summary
Negative
2024-11-05
The earnings call summary indicates declining revenues and income from operations, alongside a significant focus on Bitcoin purchases, which introduces volatility. The Q&A section reveals uncertainty regarding options trading and capital market strategies, and no clear guidance was provided. Despite tight expense control and slight net income growth, the overall sentiment is negative due to revenue declines and unclear strategic direction.
Semler Scientific, Inc. (SMLR) Q2 2024 Earnings Call Summary
Negative
2024-08-06
The earnings call reveals several negative aspects: a 22% decline in revenue, zero net income, and reliance on a few major customers. The bitcoin strategy introduces volatility and regulatory risks. Despite tight expense control and cash generation, the market's reaction is likely negative due to the revenue drop and uncertainty surrounding the bitcoin approach, compounded by unclear management responses in the Q&A.
People Also Watch

DXYZ
Destiny Tech100 Inc
28.580
USD
+13.50%

GNK
Genco Shipping & Trading Ltd
17.040
USD
+1.91%

MGIC
Magic Software Enterprises Ltd
20.680
USD
+1.08%

PLPC
Preformed Line Products Co
212.110
USD
-3.21%

LENZ
LENZ Therapeutics Inc
29.720
USD
-2.43%

LPRO
Open Lending Corp
1.900
USD
+3.26%

TRST
TrustCo Bank Corp NY
37.710
USD
+0.19%

MNTK
Montauk Renewables Inc
2.030
USD
+1.00%

EU
enCore Energy Corp
3.090
USD
-4.63%
FAQ
What were the key highlights of SMLR’s latest earnings report for FY2025Q2?
SMLR reported its FY2025Q2 earnings on 2025-08-04, showcasing a revenue of 8.22M against an estimate of 8.40M, resulting in a -2.19% surprise. The EPS was 5.04, surpassing the expected -0.27 by 1966.67% . The stock experienced a -1.41% price change on the earnings day and a 2.15% change over the next five days, reflecting market reactions to the results.





